Alpha-fetoprotein response at different time-points is associated with efficacy of nivolumab monotherapy for unresectable hepatocellular carcinoma

Nivolumab monotherapy has a modest objective response rate (ORR) in hepatocellular carcinoma (HCC). To overcome the lack of biomarkers that predict delayed alpha-fetoprotein (AFP) response beyond 4 weeks, we applied a novel 50-10 rule of AFP response for unresectable HCC patients under nivolumab mon...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Am J Cancer Res
Autors principals: Teng, Wei, Lin, Chen-Chun, Ho, Ming-Mo, Lui, Kar-Wai, Wang, Sheng-Fu, Hsu, Chao-Wei, Lin, Shi-Ming
Format: Artigo
Idioma:Inglês
Publicat: e-Century Publishing Corporation 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8167682/
https://ncbi.nlm.nih.gov/pubmed/34094688
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars